Clinical Trials Logo

Urinary Calculi clinical trials

View clinical trials related to Urinary Calculi.

Filter by:

NCT ID: NCT04387617 Completed - Urinary Stone Clinical Trials

A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones

Start date: February 15, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine if CBD oil has any effect on decreasing postoperative pain control following ureteroscopy for urinary stone disease, and to determine if CBD oil has any effect in decreasing the amount of postoperative opioids (commonly used drug) used by patients after undergoing ureteroscopy for urinary stone disease.

NCT ID: NCT04354181 Completed - Urolithiasis Clinical Trials

Urine Biomarker for Stone Recurrence

Start date: July 24, 2020
Phase:
Study type: Observational

Despite the advent of treating stones with Extracorporeal Shock Wave Lithotripsy (ESWL) and Percutaneous nephrolithotomy (PCNL), the recurrence rate for renal stones remains high and this may be due to poor compliance of patients with dietary and fluid advice, age, metabolic abnormalities, medicines and the formation of "new stones" from clinically insignificant residual fragments (CIRF). Though some patients become stone-free after ESWL/PCNL or open surgeries, the majority develop "new stones" and it is difficult to predict when these stones will recur until either they have imaging perform or they developed symptoms. However, the use of regular imaging for monitoring will be costly and involve radiation exposure. Therefore, a diagnostic tool is needed to enable the clinician and/or patient to monitor for stone recurrence. In the previous studies, some urine markers were identified that are related to stone formation. The relationship of these urine markers with the recurrence of renal stone will be further explore in this study. Also, potential markers that could predict stone recurrence will be identified, and hence earlier intervention could be offered to patients.

NCT ID: NCT04332861 Completed - Sepsis Clinical Trials

Evaluation of Infection in Obstructing Urolithiasis

eIOU
Start date: September 3, 2019
Phase:
Study type: Observational

Obstructing urolithiasis can be life-threatening in the setting of urinary tract infection. The purpose of this study is to identify and validate risk factors and markers for the presence of infection and development of sepsis among patients with obstructing urolithiasis.

NCT ID: NCT04112160 Completed - Pain Clinical Trials

Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal

Start date: June 28, 2018
Phase: Phase 2
Study type: Interventional

This is a prospective randomized double-blind controlled trial assessing the benefits of intramuscular ketorolac before or immediately after office ureteral stent removal.

NCT ID: NCT04069338 Completed - Urolithiasis Clinical Trials

Comparison of Lithotripsy Urolithiasis Machines

CoLUM
Start date: May 31, 2019
Phase: N/A
Study type: Interventional

A comparison on the outcomes of patients undergoing shockwave lithotripsy using the Storz machine versus the Dornier machine.

NCT ID: NCT03927781 Completed - Anesthesia Clinical Trials

Perioperative Pregabalin in Ureteroscopy: a Pilot

Start date: April 1, 2019
Phase: Phase 3
Study type: Interventional

The investigators propose a pilot clinical trial on the use of perioperative pregabalin in order to decrease ureteral stent related symptoms and decrease opioid usage after ureteroscopy with stent placement. Patients undergoing ureteroscopy with stent placement will receive a single dose of 300 mg pregabalin PO in the preoperative area. This work will assess safety and feasibility of studying this regimen at our institution, with the aim of performing a randomized, placebo-controlled, double-blinded study in the future.

NCT ID: NCT03526458 Completed - Surgery Clinical Trials

Clinical Trial Evaluating the Efficiency of Holmium Laser Settings on Urinary Stones

Start date: July 30, 2019
Phase: N/A
Study type: Interventional

The primary objective of this study is to compare the time to acceptable stone fragmentation during clinical use of the holmium laser when using energy settings 0.2J vs 0.8J. The hypothesis is that holmium laser energy settings 0.8J will require less time than lower energy settings 0.2J for fragmenting urinary stones. The clinical practice is to treat urinary stones until the stone is reduced to fragments ≤ 2 mm in size. This is determined by using the laser fiber which is 273 microns to visually estimate the size of the resultant fragments as described by Patel et al, J Endo 2014. Investigators will standardize the effect of stone size by creating a ratio of stone size to treatment time. In this study, the frequency is set at 15Hz. Thus, the study contains two arms: 0.2J&15Hz, and 0.8J&15Hz. Patients will be randomized into the two groups by the ratio of 1:1.

NCT ID: NCT03388060 Completed - Urologic Diseases Clinical Trials

(SWL) Versus (ODT) Versus Combined SWL And ODT For Radiolucent Stone

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

compare the efficacy of of ultrasound guided SWL versus dissolution therapy versus combined SWL and dissolution therapy in management of 1 - 2.5 cm renal stones.

NCT ID: NCT03150446 Completed - Urinary Stones Clinical Trials

The Usefulness of Flexible Cystoscopy for Preventing Double-J Stent Malposition After Laparoscopic Ureterolithotomy

FC-DM
Start date: April 1, 2009
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate the role of flexible cystoscopy in preventing malpositioning of the ureteral stent after laparoscopic ureterolithotomy in male patients. From April 2009 to June 2015, 97 male patients with stones >1.8 cm in the upper ureter underwent intracorporeal double-J stenting of the ureter after laparoscopic ureterolithotomy performed by four different surgeons. In the last 50 patients who underwent laparoscopic ureterolithotomy flexible cystoscopy was performed through the urethral route to confirm the position of the double-J stent, while in the first 47 correct positioning of the stent was confirmed through postoperative KUB.

NCT ID: NCT03111381 Completed - Pain, Postoperative Clinical Trials

Toradol to Reduce Ureteroscopic Symptoms Trial

TRUST
Start date: August 1, 2017
Phase: Phase 2
Study type: Interventional

Double blinded randomized controlled clinical trial to assess the impact of intraoperative Toradol on post-operative pain scores for patients undergoing ureteroscopy for urinary stone management.